Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 2,690 | 2,452 | 2,807 | 3,083 | 3,298 |
| Cost of Goods | N/A | N/A | 194 | 164 | 181 |
| Gross Profit | 2,690 | 2,452 | 2,613 | 2,919 | 3,117 |
| Operating Expenses | 11,131 | 0 | 11,054 | 10,271 | 15,263 |
| Operating Income | -8,441 | 2,452 | -8,247 | -7,188 | -11,965 |
| Interest Expense | 2 | 0 | 2 | 2 | 2 |
| Other Income | -640 | 0 | 101 | 104 | 231 |
| Pre-tax Income | -9,083 | 2,452 | -8,148 | -7,086 | -11,736 |
| Net Income Continuous | -9,083 | 2,452 | -8,148 | -7,086 | -11,736 |
| Net Income Discontinuous | -617 | N/A | N/A | N/A | N/A |
| Net Income | $-9,700 | $2,452 | $-8,148 | $-7,086 | $-11,736 |
| EPS Basic Total Ops | -0.26 | N/A | -0.23 | -0.20 | -0.34 |
| EPS Basic Continuous Ops | -0.24 | N/A | -0.23 | -0.20 | -0.34 |
| EPS Basic Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.26 | N/A | -0.23 | -0.20 | -0.34 |
| EPS Diluted Continuous Ops | -0.24 | N/A | -0.23 | -0.20 | -0.34 |
| EPS Diluted Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,070 | $2,847 | $-6,340 | $-5,491 | $-10,231 |